Market Tracker

08/29 6:01pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.65
Data as of Aug 29
 0.00 / 0.00%
Today’s Change
1.16
Today|||52-Week Range
3.18
+18.71%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.65
Today’s open1.65
Day’s range1.63 - 1.67
Volume481,694
Average volume (3 months)1,052,888
Market cap$295.7M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-22.73%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.08+1.18%
SCMPSucampo Pharmaceutic...+0.13+1.92%
ECYTEndocyte Inc+0.38+5.44%
SVASinovac Biotech Ltd+0.03+0.55%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateSeptember 8, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts